Related Experiment Videos
A myasthenic syndrome with congenital paucity of secondary synaptic clefts: CPSC syndrome
L M Smit1, G Hageman, H Veldman
1Laboratory for Neuromuscular Diseases, State University Utrecht, The Netherlands.
Insights
Congenital paucity of secondary synaptic clefts (CPSC) syndrome is a newly identified myasthenic disorder. This condition is characterized by reduced acetylcholine receptors and synaptic abnormalities, leading to mild neuromuscular impairment.
Area of Science:
- Neurology
- Muscle Physiology
- Pathology
Background:
- A novel myasthenic syndrome, Congenital Paucity of Secondary Synaptic Clefts (CPSC) syndrome, has been recognized.
- Understanding its clinical course and underlying pathophysiology is crucial for diagnosis and management.
Purpose of the Study:
- To investigate the clinical and pathological features of CPSC syndrome.
- To characterize the neuromuscular junction abnormalities in affected individuals.
Main Methods:
- Clinical observation over 3-6 years.
- Muscle biopsy analysis including light and electron microscopy.
- Microelectrode studies of neuromuscular transmission.
- Acetylcholine receptor (AChR) localization techniques.
Main Results:
- Patients exhibited stable symptoms after infancy, with mild handicaps.
- Microelectrode studies showed small miniature endplate potential (MEPP) amplitudes.
- Histopathology revealed type I fiber predominance, focal type-grouping, and axonal branching.
- Electron microscopy indicated reduced postsynaptic membrane folds.
- AChR studies demonstrated deficiency, altered distribution, and extrajunctional presence.
Conclusions:
- CPSC syndrome is a distinct clinicopathological entity.
- Morphological hallmark is a congenital paucity of secondary synaptic clefts.
- Neuromuscular junction defects, including AChR abnormalities, underlie the syndrome.
Abstract:
Two cases of a newly recognized myasthenic syndrome were investigated (CPSC syndrome). The course of the disease was observed for periods of 6 and 3 years. In infancy, exacerbations of the symptoms occurred during febrile illness, but thereafter the clinical course was stable and the children appeared to be only slightly handicapped. Biopsies were taken from the intercostal muscle in both patients. Microelectrode studies revealed small Mepp amplitudes. Light microscopy demonstrated predominance of type I fibers and focal type-grouping. There was a lowered cholinesterase activity and frequent branching of preterminal axons. Electron microscopy revealed that there were few, if any, folds of the postsynaptic membrane and that there were no signs of degeneration. Methods for localization of acetylcholine receptors (AChR) revealed a deficiency and altered distribution of AChRs at these postsynaptic membranes and the occurrence of extrajunctional AChRs in some muscle fibers. It is concluded that the syndrome is a clinicopathological entity, characterized morphologically by a congenital paucity of secondary synaptic clefts (CPSC syndrome).